CAICaris Life Sciences, Inc.
16.83USD+0.99%Mkt Cap: 4.73B USDP/E: Last update: 2026-06-01

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare usin…

Indicators:|

Key Statistics

Company
Market Cap4.73B USD
Enterprise Value4.33B USD
Revenue (TTM)907.29M USD
Gross Profit539.17M USD
Net Income (TTM)-68.09M USD
Revenue/Share3.963 USD
Last Price16.83 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.8K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)44.87
PEG
EV/EBITDA33.60
EV/Revenue4.78
P/S5.21
P/B7.96
EPS (TTM)-2.76
EPS (Forward)0.37
52W Range
14.199% of range42.50
52W High42.50 USD
52W Low14.19 USD
Profitability
Gross Margin66.40%
Oper. Margin2.44%
EBITDA Margin14.22%
Profit Margin-8.38%
ROE-11.79%
ROA-6.05%
Growth
Revenue Growth78.80%
Earnings Growth
Cash Flow & Leverage
Operating CF83.16M USD
CapEx (TTM)16.26M USD
FCF Margin11.25%
FCF Yield2.16%
Net Debt-392.50M USD
Net Debt/EBITDA-3.04
Balance Sheet
Debt/Equity0.74
Current Ratio7.05
Quick Ratio6.35
Book Value/Sh2.100 USD
Cash/Share2.913 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)28.00 USD
Target Range21.00 USD36.00 USD
# Analysts13
Ownership
Shares Out.282.68M
Float103.41M
Insiders48.51%
Institutions56.64%
Short Interest
Short Ratio4.5d
Short % Float10.20%
Short % Out.4.16%
Shares Short11.75M
Short (prev mo.)11.79M
Technical
SMA 5018.13 (-7.2%)
SMA 20025.29 (-33.5%)
Beta
S&P 52W Chg27.70%
Avg Vol (30d)2.57M
Avg Vol (10d)2.84M
Technical Indicators
RSI (14)48.4
MACD-0.7592
MACD Signal-0.9211
MACD Hist.+0.1620
BB Upper19.74 USD
BB Middle16.49 USD
BB Lower13.25 USD
BB Width39.36%
ATR (14)1.081 USD
Vol Ratio (20d)0.31x